Li; Zheng Jane

Patent Applications and Registrations

Patent applications and USPTO patent grants for Li; Zheng Jane.The latest application filed is for "crystalline forms of a compound for treating or preventing gout or hyperuricemia".

Company Profile

0.8.15

Li; Zheng Jane - Beijing CN
LI; Zheng Jane - Southbury CT
Li; Zheng Jane - Quaker Hill CT
Li, Zheng Jane - Quarker Hill CT

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Crystalline salts of corydalmine Grant 11,236,081 - Yang , et al. February 1, 2	2022-02-01
Crystalline Forms Of A Compound For Treating Or Preventing Gout Or Hyperuricemia App 20220024889 - YAN; Shunqi ; et al.	2022-01-27
Crystalline Salts Of Corydalmine App 20210347770 - YANG; Zheng ; et al.	2021-11-11
Solid State Forms Of Hiv Inhibitor App 20140094486 - LI; Zheng Jane ; et al.	2014-04-03
Crystal forms of an imidazole derivative Grant 7,960,407 - Haruta , et al. June 14, 2	2011-06-14
Crystal Forms Of An Imidazole Derivative App 20090018158 - Haruta; Naoaki ; et al.	2009-01-15
Crystalline Forms Of [R-(R,R)-2-(4-fluorophenyl)-beta,delta-dihydroxy-5-(1-methyl- Ethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic Acid Calcium Salt (2:1) App 20080287521 - Byrn; Stephen Robert ; et al.	2008-11-20
Crystalline forms of [R-(R, R)]-2-(4-fluorophenyl)-beta,delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4- -[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic acid calcium salt (2:1) App 20080214651 - Byrn; Stephen Robert ; et al.	2008-09-04
Crystalline forms of [R-(R,R)]-2-(4-fluorophenyl)-.beta.,.delta.-dihydroxy-5-(1-methylethyl)- -3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic acid calcium salt (2:1) Grant 7,144,915 - Byrn , et al. December 5, 2	2006-12-05
Methods for preparing P2X7 inhibitors App 20050288288 - Leonard, Jason Albert ; et al.	2005-12-29
Crystalline forms of 3-isopropyl-6-[4-(2,5-difluoro-phenyl)-oxazol-5-yl]-[1,2,4]triazolo-[4,3-A ]pyridine Grant 6,949,652 - Kang , et al. September 27, 2	2005-09-27
Crystal forms of E-2-Methoxy-N-(3-{4-[3-methyl-4-(6-methyl-pyridin-3-yloxy- )-phenylamino]-quinazolin-6-yl}-allyl)-acetamide App 20050192298 - Li, Zheng Jane ; et al.	2005-09-01
Complexes of E-2-Methoxy-N(3-{4-[3-methyl-4-(6-methyl-pyridin-3-yloxy)-phe- nylamino]-quinzazolin-6-YL}-allyl)-acetamide, their method of production, and use App 20050075354 - Li, Zheng Jane ; et al.	2005-04-07
Crystal forms of 4-[4-(4-fluorophenoxy)benzenesulfonylamino]-tetrahydropyr- an-4-carboxylic acid hydroxyamide App 20050070599 - Ewing, Marcus Douglas ; et al.	2005-03-31
Method of analysis of NIR data App 20050010374 - Li, Zheng Jane	2005-01-13
N-(indole-2-carbonyl)-b-alaninamide crystal forms App 20040152758 - Allen, Douglas J. M. ; et al.	2004-08-05
Novel crystalline forms of 3-isopropyl-6-[4-(2,5-difluoro-phenyl)-oxazol-5- -yl]-[1,2,4]triazolo-[4,3-A]pyridine App 20040143119 - Kang, Ming ; et al.	2004-07-22
Crystalline forms of [R-(R,R)]-2-(4-fluorophenyl)-beta,delta-dihydroxy-5- -(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic acid calcium salt (2:1) App 20040054193 - Byrn, Stephen Robert ; et al.	2004-03-18
N-(indole-2-carbonyl)-b-alaninamide crystal forms Grant 6,683,106 - Allen , et al. January 27, 2	2004-01-27
N-(indole-2-carbonyl)-b-alaninamide crystal forms App 20030195243 - Allen, Douglas J. M. ; et al.	2003-10-16
Crystalline forms of [R-(R,R)]-2-(4-fluorophenyl)-.beta.,.delta.-dihydroxy-5-(1-methylethyl)- 3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic acid calcium salt (2:1) Grant 6,605,729 - Byrn , et al. August 12, 2	2003-08-12
Formulations and methods for treatment of mucosal associated conditions with an immune response modifier Grant 6,486,168 - Skwierczynski , et al. November 26, 2	2002-11-26
Formulations and methods for treatment of mucosal associated conditions with an immune response modifier Grant 6,245,776 - Skwierczynski , et al. June 12, 2	2001-06-12

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.